产品优势：
（1）无血清、无需滋养层细胞；可收集无外源干扰的纯净外泌体；
（2）可应用于iPSC工业化2D和3D大规模培养和扩增；
（3）自主化、国产化的原研体系；供货稳定，高性价比；
（4）支持临床级/药品级细胞培养，培养的iPSC细胞通过了中国食品药品检定研究院质量复核；iPSC来源功能药物通过了IND默示许可。
产品规格
| 产品 | 规格 | 货号 | 存储条件 |
hiPSC/hESC培养基-ncEpic* | 1Kit | RP01001 | - |
ncEpic Basal Medium | 496mL | RP01001-01 | 2℃~8℃ |
ncEpic 125x Supplement | 4 mL | RP01001-02 | -20℃~-80℃ |
将基础液和添加物混匀配置成完全培养基，可在2℃～8℃中存储，2周内用完。
细胞形态及功能鉴定
A、B、C：连续培养的hiPSC细胞株细胞形态图示。标尺：200μm。
D：细胞表面标志物检测：SSEA4+，Tra-1-81+。E：细胞多能基因检测：OCT4+，NANOG+。
F：连续培养的hiPSC（P30）细胞核型检测：46，XX。
文献引用
Base editing-mediated splicing correction therapy for spinal muscular atrophy
2020. Xiang Lin, et al. Cell Research(IF 46.297).
Disruption of splicing-regulatory elements using CRISPR/Cas9 to rescue spinal muscular atrophy in human iPSCs and mice
2019.Jinjing Li，et al.National Science Review(IF 23.178).
Inducible Pluripotent Stem Cel-Derived Sma Extracelular Vesicles Reuvenate Senescent lood-Brain Barrier to Protect against ischemic Stroke in Aged .
2022. Qing Li, et al. ACS Nano(IF 18.0280).
ESC-sEVs Rejuvenate Senescent Hippocampal NSCs by Activating Lysosomes to Improve Cognitive Dysfunction in Vascular Dementia
2020. Guowen Hu, et al. Advanced Science(IF 17.521).
Human ESC-sEVs alleviate age-related bone loss by rejuvenating senescent bone marrow-derived mesenchymal stem cells
2020. Liangzhi Gong, et al. Journal of Extracellular Vesicles(IF 17.3378).
ESC-SEVs Reiuvenate Aging Hippocampal NSCs by Transferring SMADs to Regulate the MYT1-Eqln3-Sirt1 Axis
2021. Guowen Hu. Molecular Therapy (IF 12.9101)
更多文献引用，请拨打021-61283010详细咨询
